R.P. Scherer
This article was originally published in The Tan Sheet
Executive Summary
Michael Thomas joins as group president, North and South America, succeeding George Fotiades, who became chief operating officer of the softgel and drug delivery firm in January. Thomas is a 20-year veteran of Bayer and most recently was a consultant to a gene therapy collaborative venture between the University of Alabama at Birmingham and the Southern Research Institute...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning